Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review

Author(s):
Hassan, S.; Cannavo, A.; Gouw, S.C.; Rosendaal, F.R.; Bom, J.G. van der (0000-0001-5251-0342)
Published
2018
Publication type
Article / Letter to editor
factor VIIIhemophilia Ameta-analysisneutralizing antibodiesrisk factors
Date issued
2018-06-30
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2018), Vol. 16, no. 6, p. 1055-1068
hdl
1887/86618
doi
10.1111/jth.14124